ArticleExperimental and therapeutic medicine2018
Characteristics of pulmonary infection after mitral valve repair in patients with metabolic syndrome and its relationship with blood pressure, blood glucose and blood lipid.
Article in Experimental and therapeutic medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 5 citations in OpenAlex.
- Isolated Robotic Mitral Valve Replacement Across Body Mass Index Categories: Early Perioperative Outcomes.Journal of clinical medicine · 2026Article
- Pneumonia After Cardiovascular Surgery: Incidence, Risk Factors and Interventions.Frontiers in cardiovascular medicine · 2022Review
- Risk factors for postoperative pneumonia after cardiac surgery: a prediction model.Journal of thoracic disease · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Characteristics of pulmonary infection after mitral valve repair in patients with metabolic syndrome (MS) and its relationships with blood pressure, blood glucose and blood lipid were investigated. Clinical data of 126 patients were retrospectively analyzed, and patients were divided into infection group (n=19) and non-infection group (n=107). The differences of MS components in patients between the two groups were compared, and the distribution of pathogens and related factors of pulmonary infection were analyzed. The postoperative pulmonary infection rate was 15.08% (19/126); the body mass index (BMI), blood pressure, fasting blood glucose (FBG), triglyceride, total cholesterol, low-density lipoprotein cholesterol, the extubation time of trachea cannula, ventilator use time, rethoracotomy hemostasis rate, sternal dehiscence rate and incidence of low-cardiac-output syndrome were higher and high-density lipoprotein (HDL-C), left ventricular ejection fraction (LVEF) was lower in the infection group than that in the non-infection group (p<0.05). The rate of postoperative pulmonary infection in patients with MS was higher than in those without MS (p<0.05). Cardiac function, BMI, FBG, HDL-C, LVEF value, extubation time of trachea cannula, ventilator use time, sternal dehiscence, rethoracotomy hemostasis and low-cardiac-output syndrome were independent risk factors for pulmonary infection after mitral valve repair in patients with MS. In conclusion, pulmonary infection easily occurs in patients with MS after mitral valve repair. Taking intervention measures according to the characteristics of pulmonary infection pathogens and predisposing factors is expected to reduce the incidence of pulmonary infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.